Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Bh3i-1 | 300817-68-9 | MFCD03453544 | 98.0% | 400.31 | C15H14BrNO3S2 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY100383100MG

Encompass_Preferred

BH3I-1 is a small-molecule antagonist of the Bcl-2 family that disrupts BH3-domain interactions. Reported activities include inhibition of Bak BH3 binding to Bcl-xL (Ki 2.4 ±0.2 μM), binding to the p53/MDM2 pair (Kd 5.3 μM), and NMR evidence of targeting the BH3-binding pocket (Ki 7.8 ±0.9 μM). Supplied at ~98% purity for research use.

  • Inhibits Bak BH3 peptide binding to Bcl-xL (Ki ≈2.4 μM).
  • Binds p53/MDM2 with a reported Kd of 5.3 μM.
  • Targets the BH3-binding pocket of Bcl-xL (NMR Ki ≈7.8 μM).
  • High purity suitable for biochemical and cellular studies.
  • Available in small-scale quantities for laboratory use.

Catalog No. 50-002-13532


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.